117 related articles for article (PubMed ID: 26857856)
21. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
[TBL] [Abstract][Full Text] [Related]
22. The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis.
Pereira JX; Azeredo MC; Martins FS; Chammas R; Oliveira FL; Santos SN; Bernardes ES; El-Cheikh MC
BMC Cancer; 2016 Aug; 16():636. PubMed ID: 27526676
[TBL] [Abstract][Full Text] [Related]
23. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.
Pulaski BA; Terman DS; Khan S; Muller E; Ostrand-Rosenberg S
Cancer Res; 2000 May; 60(10):2710-5. PubMed ID: 10825145
[TBL] [Abstract][Full Text] [Related]
24. A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.
Karkada M; Weir GM; Quinton T; Sammatur L; MacDonald LD; Grant A; Liwski R; Juskevicius R; Sinnathamby G; Philip R; Mansour M
J Immunother; 2010 Apr; 33(3):250-61. PubMed ID: 20445345
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer.
Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y
Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380
[TBL] [Abstract][Full Text] [Related]
27. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
[TBL] [Abstract][Full Text] [Related]
28. Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth.
Zheng H; Zou W; Shen J; Xu L; Wang S; Fu YX; Fan W
Stem Cells Transl Med; 2016 Sep; 5(9):1216-28. PubMed ID: 27352928
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity.
Sakamoto C; Kohara H; Inoue H; Narusawa M; Ogawa Y; Hirose-Yotsuya L; Miyamoto S; Matsumura Y; Yamada K; Takahashi A; Tani K
Cancer Gene Ther; 2017 Apr; 24(4):165-174. PubMed ID: 28084317
[TBL] [Abstract][Full Text] [Related]
30. Combinatorial therapy for liver metastatic colon cancer: dendritic cell vaccine and low-dose agonistic anti-4-1BB antibody co-stimulatory signal.
Lee H; Park HJ; Sohn HJ; Kim JM; Kim SJ
J Surg Res; 2011 Jul; 169(1):e43-50. PubMed ID: 21571303
[TBL] [Abstract][Full Text] [Related]
31. Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling.
Youniss FM; Sundaresan G; Graham LJ; Wang L; Berry CR; Dewkar GK; Jose P; Bear HD; Zweit J
PLoS One; 2014; 9(10):e109162. PubMed ID: 25334026
[TBL] [Abstract][Full Text] [Related]
32. Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.
Wysocki PJ; Kazimierczak U; Suchorska W; Kotlarski M; Malicki J; Mackiewicz A
Cancer Gene Ther; 2010 Jul; 17(7):465-75. PubMed ID: 20168352
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
34. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
Lichtor T; Glick RP; Feldman LA; Osawa G; Hardman J; O- Sullivan I; Cohen EP
J Immunother; 2008 Jan; 31(1):18-27. PubMed ID: 18157008
[TBL] [Abstract][Full Text] [Related]
35. Mouse 4T1 breast tumor model.
Pulaski BA; Ostrand-Rosenberg S
Curr Protoc Immunol; 2001 May; Chapter 20():Unit 20.2. PubMed ID: 18432775
[TBL] [Abstract][Full Text] [Related]
36. Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer.
Huang F; Pan N; Wei Y; Zhao J; Aldarouish M; Wang X; Sun X; Wen Z; Chen Y; Wang L
Front Immunol; 2021; 12():707298. PubMed ID: 34589084
[TBL] [Abstract][Full Text] [Related]
37. A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model.
Kwilas AR; Ardiani A; Dirmeier U; Wottawah C; Schlom J; Hodge JW
Oncotarget; 2015 Sep; 6(29):28194-210. PubMed ID: 26317648
[TBL] [Abstract][Full Text] [Related]
38. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
[TBL] [Abstract][Full Text] [Related]
39. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
[TBL] [Abstract][Full Text] [Related]
40. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
